Lv1
55 积分 2020-12-06 加入
Endometrial Cancer and Reproductive Justice
26天前
已关闭
ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025
1个月前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
3个月前
已完结
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial
9个月前
已完结
Prognostic value of CA125 kinetics, half-life, and nadir in the treatment of epithelial ovarian cancer: a systematic review and meta-analysis
9个月前
已完结
HER2-low expression in patients with advanced or metastatic solid tumors
11个月前
已完结
Antibody-Drug Conjugates in Gynecologic Cancer
1年前
已关闭
Antibody-Drug Conjugates in Gynecologic Cancers
1年前
已完结
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
1年前
已完结
Development and Validation of Multiparametric MRI–based Radiomics Models for Preoperative Risk Stratification of Endometrial Cancer
2年前
已完结
皖公网安备34019202002308
